Chronic Venous Insufficiency Drugs
Jan 19, 2026
Chronic Venous Insufficiency Treatment: Bridging Unmet Needs with Minimally Invasive and Regenerative Solutions
Summary In the seven major markets (7MM: US, EU4, UK, Japan), diagnosed cases of CVI reached ~17 million in 2024. Prevalence is projected to grow at a 1.4% CAGR, reaching ~20 million by 2034, driven by aging populations, obesity, sedentary lifestyles, and improved diagnostics. Endovenous laser ablation...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
